Engle James R 4
4 · Talecris Biotherapeutics Holdings Corp. · Filed Apr 5, 2011
Insider Transaction Report
Form 4
Engle James R
Sr. VP, Information Technology
Transactions
- Tax Payment
Common Stock
2011-04-01$26.94/sh−912$24,569→ 3,655 total - Award
Common Stock
2011-04-01+1,936→ 4,567 total
Footnotes (2)
- [F1]The transaction reported in this row involves the settlement of performance share units into common stock that were granted pursuant to our 2009 Long-Term Incentive Plan.
- [F2]Includes restricted share units representing the right to receive 1,754 shares of the Issuer's common stock that will vest in equal annual installments on April 1, 2012 and April 1, 2013, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.